GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Lunit Inc (XKRX:328130) » Definitions » Institutional Ownership

Lunit (XKRX:328130) Institutional Ownership : 11.06% (As of May. 05, 2025)


View and export this data going back to 2022. Start your Free Trial

What is Lunit Institutional Ownership?

Institutional ownership is the percentage of shares that are owned by institutions out of the total shares outstanding. As of today, Lunit's institutional ownership is 11.06%.

Insider Ownership is the percentage of shares that are owned by company insiders relative to the total shares outstanding. As of today, Lunit's Insider Ownership is 0.00%.

Float Percentage Of Total Shares Outstanding is the percentage of float shares relative to the total shares outstanding. As of today, Lunit's Float Percentage Of Total Shares Outstanding is 0.00%.


Lunit Institutional Ownership Historical Data

The historical data trend for Lunit's Institutional Ownership can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Lunit Institutional Ownership Chart

Lunit Historical Data

The historical data trend for Lunit can be seen below:

2024-06-30 2024-07-31 2024-08-31 2024-09-30 2024-10-31 2024-11-30 2024-12-31 2025-01-31 2025-02-28 2025-03-31
Institutional Ownership 8.41 8.43 8.38 8.60 8.55 9.77 10.50 10.69 11.05 11.06

Lunit Institutional Ownership Calculation

The percentage of shares that are owned by institutions out of the total shares outstanding.


Lunit Business Description

Traded in Other Exchanges
N/A
Address
374 Gangnam-daero, 4th to 9th Floors, Case Square Gangnam II, Yeoksam-dong, Gangnam-gu, Seoul, KOR, 06241
Lunit Inc is a medical AI software company devoted to providing AI-powered total cancer care. Its products comprise of Lunit INSIGHT CXR, AI solution for Chest x-ray; Lunit INSIGHT MMG, AI solution for Mammography; Lunit SCOPE IO, AI-Powered Biomarker for Immuno-Oncology; and Lunit SCOPE PD-L1, AI Solution for PD-L1 Expression.

Lunit Headlines

No Headlines